- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Diabetes Mellitus Type 2 in Japan
Total 480 results
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Japan
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2United States, Croatia, India, Israel, Italy, Japan, Mexico, Poland, Puerto Rico, Russian Federation, Slovakia, Spain, United Kingdom
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesJapan, Malaysia, Taiwan, Korea, Republic of, Hong Kong
-
Novo Nordisk A/SCompleted
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Japan
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Japan
-
Novartis PharmaceuticalsCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Japan
-
Novo Nordisk A/SCompleted
-
Eli Lilly and CompanyCompletedObesity | Overweight | Type 2 DiabetesUnited States, Russian Federation, Taiwan, Argentina, Brazil, Japan, Puerto Rico, India
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesJapan
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Austria, Greece, Hungary, Japan, Portugal, Romania, Spain
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesJapan
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesJapan
-
Astellas Pharma IncCompletedType 1 Diabetes MellitusJapan
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
Kobe UniversityBoehringer IngelheimActive, not recruitingInsulin Resistance - Type A | Insulin Resistance - Type B | Lipoatrophic Diabetes Mellitus | Insulin Resistance SyndromeJapan
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2India, United States, Thailand, Japan, Germany, Turkey, Hungary, Malaysia, Poland, South Africa, Czechia, Italy, France, Slovenia
-
Janssen Research & Development, LLCCompletedDiabetes Mellitus, Type 2 | Renal InsufficiencyFrance, Poland, United States, Belgium, Germany, Spain, India, Romania, South Africa, Canada, Australia, Korea, Republic of, New Zealand, Russian Federation, Brazil, Malaysia, Latvia, Mexico
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2United States, Japan, Hungary, Poland, Russian Federation, Bulgaria, Serbia, Greece, Denmark
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesJapan
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Argentina, Hungary, India, Japan, Poland, Russian Federation
-
Novo Nordisk A/SCompletedHealthy Volunteers Type 2 DiabetesJapan
-
Kobe UniversityBoehringer IngelheimActive, not recruitingInsulin Resistance - Type A | Insulin Resistance - Type B | Lipoatrophic Diabetes Mellitus | Insulin Resistance SyndromeJapan
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Japan
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Russian Federation, Canada, Austria, Japan, Norway, Puerto Rico
-
Boehringer IngelheimCompleted
-
Novo Nordisk A/SRecruitingDiabetes Mellitus, Type 2United States, Korea, Republic of, Australia, India, Canada, Japan, South Africa
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 1Japan
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Russian Federation, Mexico, Japan, Serbia, Turkey, Italy, Czechia, Bulgaria, Algeria, Romania
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, United Kingdom, Mexico, Russian Federation, Japan, Canada, Italy, South Africa, Romania
-
SanofiCompletedDiabetes Mellitus, Type 1Japan
-
Novo Nordisk A/SCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Japan
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2United States, Poland, Puerto Rico, Canada, Hungary, Greece, Japan, Bulgaria, Slovakia, Ukraine, Czechia
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Poland, Croatia, Japan, Slovakia, Germany, Latvia, South Africa, Czechia, United Arab Emirates, Hungary, Ukraine, Puerto Rico
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Slovakia, Japan, Puerto Rico, Serbia, Germany
-
TheracosCompletedDiabetes Mellitus, Type 2United States, Japan
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, India, Japan, Puerto Rico, Canada, France, Mexico, Poland, Russian Federation, Greece
-
Hiroshima UniversitySBI Pharmaceuticals Co, Ltd.Completed
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesIndia, Japan, Russian Federation, Spain, Sweden, Argentina, Hungary, Norway, South Africa, Turkey, Bulgaria, Romania, Thailand, Portugal, Hong Kong, Mexico, Ukraine, Czechia
-
Novo Nordisk A/SCompletedHeart Failure With Preserved Ejection Fraction (HFpEF) and Diabetes Mellitus, Type 2United States, Spain, Hungary, United Kingdom, India, Netherlands, Germany, Japan, Canada, Czechia, Argentina, Austria, Israel, Italy, Poland, Sweden
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2United States, China, Taiwan, Canada, Switzerland, Japan, Brazil, Russian Federation, Hungary, Greece, France, Israel, Sweden, Slovakia
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, India, Israel, Japan, Russian Federation, United Kingdom, France, Mexico, South Africa, Turkey, Argentina, Germany, Romania, Brazil, Ukraine
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Japan
-
Sanwa Kagaku Kenkyusho Co., Ltd.CompletedType 1 Diabetes MellitusJapan
-
BayerCompleted
-
Janssen Research & Development, LLCThe George Institute for Global Health, AustraliaCompletedDiabetes Mellitus, Type 2 | Diabetic NephropathyUnited States, Canada, France, Germany, Poland, Ukraine, United Kingdom, China, Taiwan, Spain, Argentina, Colombia, Mexico, Bulgaria, India, Malaysia, Romania, Serbia, South Africa, Japan, Australia, Korea, Republic of, Chile, New Zealand and more
-
Mitsubishi Tanabe Pharma CorporationCompletedDiabetic NephropathyJapan
-
Daiichi Sankyo, Inc.Completed